Christopher Moreau was appointed president and CEO of Miraculins this week, replacing Jim Charlton who stepped down. Charlton remains a member of Miraculin’s board and will continue to provide guidance to the company, it said in a statement.
Moreau had served as vice president of business development since joining the company in March 2006. Before that he was president of Advansis Capital, a privately held Canadian financial services firm. The company did not disclose Moreau’s new salary, but said that it has granted him 130,000 stock options at an excise price of CA$.53 per share.